Dimensional Fund Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-509,059
Closed -$50.1M 3274
2025
Q2
$50.1M Sell
509,059
-275
-0.1% -$26K 0.01% 1495
2025
Q1
$47.2M Buy
509,334
+5,943
+1% +$548K 0.01% 1503
2024
Q4
$45.7M Sell
503,391
-5,894
-1% -$541K 0.01% 1561
2024
Q3
$49.2M Sell
509,285
-4,881
-0.9% -$476K 0.01% 1526
2024
Q2
$47.2M Buy
514,166
+19,660
+4% +$1.82M 0.01% 1503
2024
Q1
$45.6M Sell
494,506
-17,135
-3% -$1.61M 0.01% 1518
2023
Q4
$48.6M Sell
511,641
-169,675
-25% -$15.8M 0.01% 1469
2023
Q3
$63.6M Sell
681,316
-40,020
-6% -$3.7M 0.02% 1166
2023
Q2
$66M Buy
721,336
+213,269
+42% +$17.5M 0.02% 1159
2023
Q1
$37.4M Buy
508,067
+97,488
+24% +$8.43M 0.01% 1548
2022
Q4
$34.3K Buy
410,579
+22,882
+6% +$2.06M 0.01% 1564
2022
Q3
$37.5M Buy
387,697
+15,610
+4% +$1.86M 0.01% 1442
2022
Q2
$39.1M Buy
372,087
+20,704
+6% +$2.65M 0.01% 1482
2022
Q1
$60.5M Buy
351,383
+17,499
+5% +$2.61M 0.02% 1246
2021
Q4
$54.1M Buy
333,884
+4,508
+1% +$724K 0.02% 1359
2021
Q3
$49.1M Buy
329,376
+75,805
+30% +$15.8M 0.02% 1422
2021
Q2
$62.1M Sell
253,571
-986
-0.4% -$259K 0.02% 1260
2021
Q1
$67.4M Sell
254,557
-146,371
-37% -$41.3M 0.02% 1166
2020
Q4
$118M Sell
400,928
-137,130
-25% -$35.2M 0.04% 612
2020
Q3
$127M Sell
538,058
-133,583
-20% -$30.4M 0.05% 407
2020
Q2
$133M Sell
671,641
-86,913
-11% -$16.2M 0.06% 360
2020
Q1
$139M Sell
758,554
-31,226
-4% -$5.56M 0.07% 235
2019
Q4
$132M Sell
789,780
-28,542
-3% -$4.24M 0.05% 526
2019
Q3
$107M Sell
818,322
-32,801
-4% -$4.27M 0.04% 623
2019
Q2
$103M Sell
851,123
-34,780
-4% -$4.13M 0.04% 644
2019
Q1
$109M Sell
885,903
-115,301
-12% -$14.5M 0.04% 594
2018
Q4
$117M Sell
1,001,204
-60,472
-6% -$7.13M 0.05% 419
2018
Q3
$133M Sell
1,061,676
-52,627
-5% -$5.81M 0.05% 477
2018
Q2
$95.2M Sell
1,114,303
-61,492
-5% -$4.52M 0.04% 695
2018
Q1
$70.9M Buy
1,175,795
+989
+0.1% +$56.3K 0.03% 942
2017
Q4
$61.9M Sell
1,174,806
-9,618
-0.8% -$507K 0.03% 1103
2017
Q3
$66.3M Buy
1,184,424
+59,481
+5% +$3.15M 0.03% 964
2017
Q2
$70.7M Buy
1,124,943
+7,963
+0.7% +$464K 0.03% 829
2017
Q1
$57.1M Sell
1,116,980
-271,023
-20% -$12.9M 0.03% 1041
2016
Q4
$59.2M Sell
1,388,003
-187,778
-12% -$7.98M 0.03% 933
2016
Q3
$74.8M Buy
1,575,781
+30,564
+2% +$1.53M 0.04% 642
2016
Q2
$78M Sell
1,545,217
-7,350
-0.5% -$371K 0.04% 563
2016
Q1
$75M Sell
1,552,567
-272,825
-15% -$10.5M 0.04% 552
2015
Q4
$71.8M Sell
1,825,392
-88,769
-5% -$3.55M 0.04% 557
2015
Q3
$72.7M Sell
1,914,161
-3,491
-0.2% -$147K 0.05% 512
2015
Q2
$76.2M Sell
1,917,652
-76,580
-4% -$2.39M 0.05% 527
2015
Q1
$53.4M Sell
1,994,232
-10,852
-0.5% -$306K 0.03% 770
2014
Q4
$58.9M Sell
2,005,084
-6,593
-0.3% -$163K 0.04% 625
2014
Q3
$40.6M Sell
2,011,677
-54,012
-3% -$1.04M 0.03% 866
2014
Q2
$34.6M Sell
2,065,689
-76,440
-4% -$1.08M 0.02% 1049
2014
Q1
$31.9M Buy
2,142,129
+37,373
+2% +$575K 0.02% 1054
2013
Q4
$30.8M Buy
2,104,756
+238,339
+13% +$3.84M 0.02% 1041
2013
Q3
$32.1M Buy
1,866,417
+244,781
+15% +$3.63M 0.03% 892
2013
Q2
$18.8M Buy
+1,621,636
New +$18.6M 0.02% 1353

Other funds holding AMED

Dimensional Fund Advisors's AMED Position: Q3 2025 in Review

Dimensional Fund Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 509,059 shares — an estimated $50.1M sold.

Dimensional Fund Advisors first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $139M in Q1 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Dimensional Fund Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 509,059 Amedisys shares in Q3 2025, an estimated $50.1M.
  • Dimensional Fund Advisors first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Dimensional Fund Advisors's Amedisys position peaked at $139M in Q1 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.